MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
UBS
UBS Group AG
There isn't enough reported data to score UBS yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
UBS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
UBS's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like UBS.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over UBS in the historical PE scenario, which offers more potential upside but is not a forecast.
UBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $17.70 | -63% |
| Fair | 9.8x | $23.26 | -52% |
| Forward | 11x | $48.44 | — |
| Current | 20x | $48.44 | — |
| Expensive | 21x | $49.06 | +1.3% |
Historical ranges are pointers, not guarantees.
UBS's PE is 20x, but its earnings don't support one, so it isn't a reliable read right now.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
UBS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for UBS, with profitability improving.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
UBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.32 | +82% |
| Q4 2025 | $2.38 | +57% |
| Q2 2025 | $1.91 | +19000% |
| Q1 2025 | $1.53 | -81% |
| Q4 2024 | $1.52 | -81% |
| Q2 2024 | $0.01 | -100% |
| Q1 2024 | $8.18 | +317% |
| Q4 2023 | $7.98 | +255% |
| Q2 2023 | $9.86 | +340% |
UBS has the edge over MS in the latest year-over-year earnings comparison.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
UBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $24.9B | +3.9% |
| Q2 2025 | $18.3B | -0.2% |
| Q1 2025 | $18.9B | -3.4% |
| Q4 2024 | $24B | +6.3% |
| Q2 2024 | $18.3B | +33% |
| Q1 2024 | $19.6B | +71% |
| Q4 2023 | $22.6B | +39% |
| Q2 2023 | $13.8B | +58% |
UBS has the edge over MS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 18% | +11 points |
| Q2 2025 | 12% | +1 points |
| Q1 2025 | 11% | +20 points |
| Q4 2024 | 12% | -168 points |
| Q2 2024 | 7.2% | -4.7 points |
| Q1 2024 | 11% | -15 points |
| Q4 2023 | -8.8% | -38 points |
| Q2 2023 | 180% | +153 points |
UBS's operating margin was 18% last quarter, up 11 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
UBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $5B | +$5.1B |
| Q1 2025 | $14.8B | +33% |
| Q2 2024 | -$186M | -100% |
| Q1 2024 | $11.1B | +$36.6B |
| Q2 2023 | $42.3B | +$51.8B |
| Q1 2023 | -$25.5B | -195% |
| Q2 2022 | -$9.5B | -$6.5B |
| Q1 2022 | $26.9B | +$26.9B |
UBS's free cash flow was $30.7B over the past year, down 10% from the year before. Free cash flow isn't a meaningful measure for financial services companies like UBS.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
UBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -16.3M shares |
| 1 year | -2.1% | -69M shares |
| 3 years | -9.3% | -337M shares |
| 5 years | -15% | -563M shares |
UBS has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $619.1M |
| Q1 2025 | $1.3B |
| Q2 2024 | $813M |
| Q1 2024 | $969.1M |
| Q2 2023 | $78.1M |
| Q1 2023 | $2.2B |
| Q2 2022 | $1.6B |
| Q1 2022 | $1.9B |
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
UBS Net Leverage
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
UBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.9 | Neutral |
| Stochastic | 20.3 | Neutral |
UBS's weekly RSI is 49 (neutral) and its Stochastic is 20 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over UBS on valuation relative to its sector.
UBS PE vs Financial Services Sector
| Metric | UBS | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 13x | 56% above |
| PE % | 83 | 63 | 20 pts above |
UBS is trading at 20x earnings, a 56% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
UBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.9 | 1.1% above |
| 20 week MA | $51.0 | 5% below |
| 50 week MA | $46.9 | 3.4% above |
| 100 week MA | $40.9 | 18% above |
| 200 week MA | $33.8 | 43% above |
UBS has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over UBS on returns for 2026, with the stronger performance.
UBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.5 | $14.1 | +13% |
| 2021 | $14.1 | $17.8 | +27% |
| 2022 | $17.8 | $18.6 | +4.5% |
| 2023 | $18.6 | $30.9 | +66% |
| 2024 | $30.9 | $30.7 | -0.7% |
| 2025 | $30.7 | $47.3 | +54% |
| 2026 YTD | $47.3 | $48.4 | +2.5% |
UBS has finished higher in five of the last six years, two of them by more than 50%. It's up 2.5% so far in 2026.